Deucravacitinib (Sotyktu)

Deucravacitinib · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Deucravacitinib (Sotyktu), covering 2025-06-08 to 2025-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Deucravacitinib to Treat LPP and FFA [Phase 2]